Target Group, Inc. (Canada) (CBDY)
0.0012
0.00 (0.00%)
USD |
OTCM |
Aug 28, 16:00
Target Group Free Cash Flow : -1.168M for June 30, 2026
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| June 30, 2026 | -1.168M |
| March 31, 2026 | -0.4808M |
| December 31, 2025 | -0.917M |
| September 30, 2025 | 0.0634M |
| June 30, 2025 | 0.248M |
| March 31, 2025 | 0.7513M |
| December 31, 2024 | 2.093M |
| September 30, 2024 | 1.636M |
| June 30, 2024 | 1.435M |
| March 31, 2024 | 0.3524M |
| December 31, 2023 | -0.6063M |
| September 30, 2023 | -0.8239M |
| June 30, 2023 | -0.1245M |
| March 31, 2023 | -1.350M |
| December 31, 2022 | -1.015M |
| September 30, 2022 | -0.4587M |
| June 30, 2022 | -0.8239M |
| March 31, 2022 | 0.5158M |
| December 31, 2021 | 0.1001M |
| September 30, 2021 | -0.725M |
| June 30, 2021 | -0.8151M |
| March 31, 2021 | -0.8737M |
| December 31, 2020 | -1.476M |
| September 30, 2020 | -1.525M |
| Date | Value |
|---|---|
| June 30, 2020 | -3.093M |
| March 31, 2020 | -7.093M |
| December 31, 2019 | -9.334M |
| September 30, 2019 | -10.38M |
| June 30, 2019 | -9.570M |
| March 31, 2019 | -5.559M |
| December 31, 2018 | -2.504M |
| September 30, 2018 | -1.248M |
| June 30, 2018 | -0.2288M |
| March 31, 2018 | -0.2462M |
| December 31, 2017 | -0.2621M |
| September 30, 2017 | -0.351M |
| June 30, 2017 | -0.4482M |
| March 31, 2017 | -0.5191M |
| December 31, 2016 | -0.5586M |
| September 30, 2016 | -0.4649M |
| June 30, 2016 | -0.3354M |
| March 31, 2016 | -0.2352M |
| December 31, 2015 | -0.1799M |
| September 30, 2015 | -0.1348M |
| June 30, 2015 | -0.1078M |
| March 31, 2015 | -0.0642M |
| December 31, 2014 | -0.0091M |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Lexaria Bioscience Corp. | -7.527M |
| InMed Pharmaceuticals, Inc. | -7.710M |
| NervGen Pharma Corp. | -18.43M |
| Milestone Pharmaceuticals, Inc. | -61.10M |
| Clearmind Medicine, Inc. | -6.292M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -0.2229M |
| Cash from Investing (Quarterly) | -0.0065M |
| Cash from Financing (Quarterly) | 0.0309M |
| Free Cash Flow Per Share (Quarterly) | -0.0004 |
| Free Cash Flow to Equity (Quarterly) | -0.0065M |
| Free Cash Flow to Firm (Quarterly) | 0.0598M |
| Free Cash Flow Yield | -157.7% |